Skip to content

Study on the application of remifentanil besylate assisted sedation in interscalene brachial plexus block

Study on the application of remifentanil besylate assisted sedation in interscalene brachial plexus block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125342
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-05-26
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interscalene Brachial Plexus Block

Interventions

A Group:Remazolam Besylate sedation
B Group:propofol sedation

Sponsors

The 960th Hospital of the PLA Joint Logistice Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.18-65 years of age, regardless of gender 2.ASA grade I-III 3.Unilateral upper limb surgery was planned, and ultrasound-guided interscalene brachial plexus block was planned 4.Body mass index ( BMI ) 18-30 kg / m^2 5.Signed informed consent

Exclusion criteria

Exclusion criteria: 1.Allergic to benzodiazepines, propofol, bupivacaine or liposome drugs 2.Severe liver and kidney dysfunction ( Child-Pugh C or eGFR < 30 ml / min ) 3.Difficult airways, severe respiratory diseases, uncontrolled epilepsy 4.Long-term use of sedative, analgesic or psychiatric drugs 5.Pregnant or lactating women 6.Communication barriers, unable to complete the score

Design outcomes

Primary

MeasureTime frame
Depth of sedation ( intraoperative BIS value );The incidence of intraoperative hypotension;

Secondary

MeasureTime frame
recovery time;recovery quality;patient satisfaction;Total dosage of sedatives;chill;

Countries

China

Contacts

Public ContactZhao Xiaohong

The 960th Hospital of the PLA Joint Logistice Support Force

jinanmazuizhx@163.com+86 137 9313 2709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026